NEW YORK, May 12, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH), a patient focused biopharmaceutical company, today announced that they have entered into a mutual agreement with Algorithm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback